Beauty company selling microneedle patch cosmetics that mould into the skin to treat wrinkles and pores, tuned by facial area.

Conservative Japanese consumers would stick dissolving hyaluronic-acid microneedles on their skin if blind-tested quality proved the products work.

Vice president Asako Horikawa's team worried Japanese customers would find sticking needle patches on their bodies uncomfortable, ran a blind test for product quality, and decided to sell microneedle cosmetics after the results.

The line grew by facial area: Miken Deep Patch in July 2019, Odeko Deep Patch in September 2019 and Cheek Pore Patch in March 2020 — adjusting cosmetic ingredients, needle shape and the distance between needles for each area rather than just changing patch shapes.

The first product became a mega-hit at one sale every four seconds, and newcomers kept entering the ¥8 billion Japanese microneedle patch market; the company held off medical applications of the technology but said it could review them if customers wanted.

First-mover in Japan's cosmetic microneedle niche, in the world's largest microneedle patch market.

Blind quality testing answered the acceptance risk before launch instead of after.

Per-area product variants (eyes, mouth corners, forehead, cheek pores) widened the line without diluting the mechanism.

Tuning needle shape, spacing and ingredients per zone built product depth rivals had to reverse-engineer.

Entering a conservative market with an alien format works when you de-risk the product with blind quality tests first, then localise by use case instead of restyling one hero SKU.

As of 27 March 2022 Kitanotatsujin was still expanding the patch line and openly weighing a move into medical applications of microneedle technology.

FOLLOW THE EVIDENCE

The sources

  1. Kitanotatsujin seeks to expand presence of microneedle technology in Japan koreatimes.co.kr